Interim report Q1, 2023: Good start to the year
First quarter · Sales of SEK 854 (752) million, an increase of 14%, and 9% in local currencies excluding discontinued business. · In local currencies Consumables sales increased by 12%, Technologies 7% and Genetic Services excluding discontinued business by 7%. · Growth, in local currencies and excluding discontinued business, in all market regions APAC 23%, Americas 6% and EMEA 1%. · Gross margin increased to 56.8% (55.7). · Operating income before depreciation and amortisation (EBITDA) was SEK 262 (228) million. Adjusted for non-recurring cost of SEK 20 million, EBITDA